ClinicalTrials.gg
Drug

Amifampridine clinical trials

Also written Firdapse.

studies test it
16
open now
1
in phase 3
9
first study started
1994

How each study uses Amifampridine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Amifampridine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 Nov 2018 · FIRDAPSE · NDA 208078 (FDA, Drugs@FDA)
European Union
23 Dec 2009 · Firdapse (previously Zenas) · EMEA/H/C/001032 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Amifampridine Phosphate
6
3,4-diaminopyridine
5
Amifampridine
2

Brand

Firdapse
2

Studies by the year they started

16 studies that test it; most in 2011 (2)

Studies that test Amifampridine, by start year
YearStudies
19941
20051
20061
20081
20112
20121
20162
20182
20192
20211
20232

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
6
Phase 3
9
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 8

Catalyst Pharmaceuticals, Inc. (7) · Assistance Publique - Hôpitaux de Paris (2) · Augusta University (1) · Centre Hospitalier Universitaire, Amiens (1) · Wake Forest University Health Sciences (1) · Jacobus Pharmaceutical (1) · FDA Office of Orphan Products Development (1) · University of Aarhus (1)

Often tested with

Tested in the same studies.

Pyridostigmine (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Amifampridine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 16

Codes

What other systems call Amifampridine · ClinicalTrials.gg INT006805

  • MeSH (NLM) D000077770AmifampridineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) RU4S6E2G0JAMIFAMPRIDINEConfirmed FDA, NLM, Wikidata
  • RxNorm 2106338Confirmed FDA, Wikidata
  • Wikidata Q411707amifampridineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C82687AmifampridineOne source FDA
  • DrugBank DB11640One source Wikidata

Also registered as amifampridine phosphate (UNII 8HF8FIN815 · RxNorm 2106337).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.